These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27650425)

  • 1. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
    Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
    Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
    Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
    Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.
    Bozkaya YT; Eroğlu Z; Kayikçioğlu M; Payzin S; Can LH; Kültürsay H; Hasdemir C
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():98-100. PubMed ID: 17584695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
    Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
    Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
    J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.
    Subbiah RN; Gollob MH; Gula LJ; Davies RW; Leong-Sit P; Skanes AC; Yee R; Klein GJ; Krahn AD
    Can J Cardiol; 2010 Apr; 26(4):208-12. PubMed ID: 20386770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
    Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
    Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes.
    Kurita T; Ohe T; Marui N; Aihara N; Takaki H; Kamakura S; Matsuhisa M; Shimomura K
    Am J Cardiol; 1992 Mar; 69(6):628-33. PubMed ID: 1536113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased propensity of women to develop torsades de pointes during complete heart block.
    Kawasaki R; Machado C; Reinoehl J; Fromm B; Baga JJ; Steinman RT; Lehmann MH
    J Cardiovasc Electrophysiol; 1995 Nov; 6(11):1032-8. PubMed ID: 8589872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.
    Goutelle S; Sidolle E; Ducher M; Caron J; Timour Q; Nony P; Gouraud A
    Drugs Aging; 2014 Aug; 31(8):601-9. PubMed ID: 24923384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes.
    Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A
    Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
    Antonelli D; Rozner E; Freedberg NA; Turgeman Y
    Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.